Precision Health Informatics

Dr. White, a veteran medical oncologist who previously held senior executive roles at Texas Oncology, serves as a strategic consulting advisor. He earned his medical degree from the University of Pittsburgh and has served on national oncology policy boards.

A practicing hematologist/oncologist, executive, and former strategic venture capitalist, Dr. Gandhi leads technology and AI investment decisions, data curation, and business development at the company. He completed Harvard Business School's Advanced Management Program and holds an MBA and medical training.

Brisbin leads the precision medicine program at Texas Oncology, focused on clinical diagnostic pathways, genomic profiling, and molecular data management. She holds degrees in biology and molecular biology plus a Master of Legal Studies in healthcare law, with prior experience at NIH, Roche Molecular Systems, and Novartis.

A practicing hematologist and medical oncologist, Dr. Chittoor serves as CMO, focusing on precision oncology education and collaboration with life sciences partners. He trained at Georgetown University Medical Center and is licensed to practice in Texas, Florida, and California.

Dr. Freitas leads bioinformatics strategy and machine learning efforts to derive clinical insights. He holds a Ph.D. in Microbiology, was a postdoctoral scientist at Los Alamos National Laboratory, and previously held bioinformatics leadership roles at Quest Diagnostics and med fusion.